REFERENCES
- Bellmann B., Muhle H., Creutzenberg O., Ernst H., Muller M., Bernstein D. M., Riego Sintes J. M. Calibration study on subchronic inhalation toxicity of man-made vitreous fibers in rats. Inhal. Toxicol. 2003; 15(12)1147–1177, [PUBMED], [INFOTRIEVE], [CSA]
- Berger A., Havet N., Vial D., Arbibe L., Dumarey C., Watson M. L., Touqui L. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. Am. J. Respir. Crit. Care. Med. 1999; 159(2)613–618, [PUBMED], [INFOTRIEVE], [CSA]
- Borron P., McIntosh J. C., Korfhagen T. R., Whitsett J. A., Taylor J., Wright J. R. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2000; 278(4)L840–847, [PUBMED], [INFOTRIEVE], [CSA]
- Ding L., Morimoto Y., Oyabu T., Kim H. N., Ogami A., Yatera K., Hirohashi M., Yamato H., Hori H., Higashi T., Tanaka I. Gene expression of Clara cell secretory protein, surfactant protein-A and thyroid transcription factor-1 in the lungs of rats exposed to potassium octatitanate whiskers in vivo. J. Occup. Health 2001; 43(3)111–117, [CSA]
- Dobbs L. G., Mason R. J. Stimulation of secretion of disaturated phosphatidylcholine from isolated alveolar type II cells by 12-O-tetradecanoyl-13-phorbol acetate. Am. Rev. Respir. Dis. 1978; 118(4)705–733, [PUBMED], [INFOTRIEVE], [CSA]
- Driscoll K. E., Maurer J. K., Lindenschmidt R. C., Romberger D., Rennard S. I., Crosby L. Respiratory tract responses to dust: Relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol. Appl. Pharmacol. 1990; 106: 88–101, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hickling T. P., Sim R. B., Malhotra R. Induction of TNF-alpha release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS Lett. 1998; 16(1–2)65–69, 437[CROSSREF], [CSA]
- Honda Y., Tsunematsu K., Suzuki A., Akino T. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung 1988; 166(5)293–301, [PUBMED], [INFOTRIEVE], [CSA]
- Horiuchi T., Mason R. J., Kuroki Y., Cherniack R. M. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat. Am. Rev. Respir. Dis. 1990; 141(4 Pt 1)1006–1013, [PUBMED], [INFOTRIEVE], [CSA]
- Horiuchi T., Ikegami M., Cherniack R. M., Mason R. J. Increased surface tension of the lung and surfactant in bleomycin-induced pulmonary fibrosis in rats. Am. J. Respir. Crit. Care Med. 1996; 154(4)1002–1005, [PUBMED], [INFOTRIEVE], [CSA]
- Kim Y. K., Jang Y. Y., Han E. S., Lee C. S. Depressant effect of ambroxol on stimulated functional responses and cell death in rat alveolar macrophages exposed to silica in vitro. J. Pharmacol. Exp. Ther. 2002; 300(2)629–637, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- LeVine A. M., Gwozdz J., Stark J., Bruno M., Whitsett J., Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 1999; 103(7)1015–1021, [PUBMED], [INFOTRIEVE], [CSA]
- Morimoto Y., Tsuda T., Yamato H., Oyabu T., Higashi T., Tanaka I. Comparison of gene expression of cytokines mRNA in lungs of rats induced by intratracheal instillation and inhalation of mineral fibers. Inhal. Toxicol. 2001; 13: 589–601, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ogami A., Morimoto Y., Yamato H., Oyabu T., Kajiwara T., Tanaka I. Patterns of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhal. Toxicol. 2004; 16(11/12)793–801, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oyabu T., Tanaka I., Ishimatsu S., Yamato H., Morimoto Y., Tsuda T., Hori H., Higashi T. Effect of exposure period and lung burden on clearance rate of inhaled aluminum-silicate ceramic fiber from rat lung. Ann. Occup. Hyg 1997; 41(1)210–212, [CSA]
- Robinson P. C., Watters L. C., King T. E., Mason R. J. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am. Rev. Respir. Dis. 1988; 137(3)585–591, [PUBMED], [INFOTRIEVE], [CSA]
- Sano K., Voelker D. R., Mason R. J. Involvement of protein kinase C in pulmonary surfactant secretion from alveolar type II cells. J. Biol. Chem. 1985; 260(23)12725–12729, [PUBMED], [INFOTRIEVE], [CSA]
- Slomiany A., Murty V. L., Aono M., Snyder C. E., Herp A., Slomiany B. L. Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis. Biochim. Biophys. Acta 1982; 710(1)106–111, [PUBMED], [INFOTRIEVE], [CSA]
- Steinberg F., Rehn B., Kraus R., Quabeck K., Bruch J., Beelen D. W., Schaefer U. W., Streffer C. Activity testing of alveolar macrophages and changes in surfactant phospholipids after irradiation in bronchoalveolar lavage: Experimental and clinical data. Environ. Health Perspect. 1992; 97: 171–175, [PUBMED], [INFOTRIEVE], [CSA]
- Wilsher M. L., Hughes D. A., Haslam P. L. Immunoregulatory properties of pulmonary surfactant: Influence of variations in the phospholipid profile. Clin. Exp. Immunol. 1988a; 73(1)117–122, [PUBMED], [INFOTRIEVE], [CSA]
- Wilsher M. L., Hughes D. A., Haslam P. L. Immunomodulatory effects of pulmonary surfactant on natural killer cell and antibody-dependent cytotoxicity. Clin. Exp. Immunol. 1988b; 74(3)465–470, [PUBMED], [INFOTRIEVE], [CSA]
- Yasuda K., Sato A., Nishimura K., Chida K., Hayakawa H. Phospholipid analysis of alveolar macrophages and bronchoalveolar lavage fluid following bleomycin administration to rabbits. Lung 1994; 172(2)91–102, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zimmerman P. E., Voelker D. R., McCormack F. X., Paulsrud J. R., Martin W. J., 2nd. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 1992; 89(1)143–149, [PUBMED], [INFOTRIEVE], [CSA]